Good to hear in the write up they mention they are still investigating imyc but no longer promising anything until they are sure. If eye disease with 4-8000 patients is worth 1billion then imagine what imyc could potentially be worth. I initially thought it needed to be useable by iv injection and we were struggling due to off target effects as it tries to reach cancer cells or tumirs. Having heard of many cases now that are tumors that are inoperable and often fatal in near term then surely there must be a demand for something that could be injected into a tumor directly and reduce or kill it, even if it can't cure interstatial type. Can we do that now? Could we potentially do that? Surely if injected directly it gives similar isolated effect as eye that is currently showing such promise. I still find it sad we never seemed to work with omomyc but surely we were told imyc was better and we own it?? Doesnt even need a separately funded company to progress it?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)